Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             279 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal factor H/FHRS proteins in sera from aHUS patients reveal novel CFH/CFHRS gene rearrangements of potential pathological relevance Alba-Dominguez, Maria
2012
217 11 p. 1134-1135
2 p.
artikel
2 Achieving efficient systemic delivery of oncolytic Vaccinia virus Evgin, Laura
2012
217 11 p. 1135-
1 p.
artikel
3 Activation of the classical complement pathway in lung cancer: A novel biomarker for diagnosis and prognosis Ajona, Daniel
2012
217 11 p. 1135-
1 p.
artikel
4 Activation of the lectin pathway of complement in pig to human xenotransplantation: Role of natural IgM Bongoni, Anjan Kumar
2012
217 11 p. 1135-1136
2 p.
artikel
5 AFFITOPE®-based vaccination against C5a alleviates disease progression in a mouse model of Alzheimer's disease Landlinger, Christine
2012
217 11 p. 1136-
1 p.
artikel
6 Allogeneic bone marrow transplantation restores complement function in human hereditary C1q deficiency Olsson, Richard
2012
217 11 p. 1136-
1 p.
artikel
7 Amyloid beta (AB) as a local regulator of complement activation? Veerhuis, Robert
2012
217 11 p. 1136-1137
2 p.
artikel
8 An alternative role of C1q in bacterial infections: Facilitating Streptococcus pneumoniae adherence and invasion of host cells Agarwal, Vaibhav
2012
217 11 p. 1137-
1 p.
artikel
9 Analysis of genes coding for CD46, CD55 and C4b-binding protein in patients with idiopathic, recurrent, spontaneous pregnancy loss Mohlin, Frida C.
2012
217 11 p. 1138-
1 p.
artikel
10 Analysis of the unique interaction of factor H with the periopathogen Treponema denticola: The paradox of factor H cleavage Miller, Daniel P.
2012
217 11 p. 1139-
1 p.
artikel
11 An engineered construct combining complement regulatory and surface recognition domains as a minimal-size functional factor H Hebecker, Mario
2012
217 11 p. 1137-
1 p.
artikel
12 A new FH autoantibody-induced murine aHUS model reveals a major protective role of decay-accelerating factor in the pathogenesis of ahus due to FH dysfunction Miwa, Takashi
2012
217 11 p. 1130-1131
2 p.
artikel
13 An ex vivo posttreatment model of sepsis: Effect on inflammation by adding complement- and CD14-inhibitors after E. coli to human whole blood Egge, Kjetil H.
2012
217 11 p. 1137-1138
2 p.
artikel
14 An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumor cells with low CD20 expression levels Derer, Stefanie
2012
217 11 p. 1138-
1 p.
artikel
15 Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells Martin, Myriam
2012
217 11 p. 1139-
1 p.
artikel
16 A novel assay to quantitate MASP-2/ficolin-3 complexes in serum Csuka, Dorottya
2012
217 11 p. 1131-
1 p.
artikel
17 A novel complement-mediated pathway for human TH2 induction via direct epithelial cell/T cell crosstalk Fara, Antonella F.
2012
217 11 p. 1219-1220
2 p.
artikel
18 A novel factor H-FC chimeric immunotherapeutic molecule against Neisseria gonorrhoeae Shaughnessy, Jutamas
2012
217 11 p. 1131-
1 p.
artikel
19 A novel hybrid CFHR2/CFHR5 gene develops MPGN II and provides insights into disease mechanism and therapeutic implications Chen, Qian
2012
217 11 p. 1131-1132
2 p.
artikel
20 A novel method for detection of eculizumab in complex with C5: Application in serum from a pregnant patient and her newborn child Bergseth, Grethe
2012
217 11 p. 1132-
1 p.
artikel
21 A novel non-coding mutation in C1q that causes C1q deficiency associated with recurrent infections Trouw, Leendert
2012
217 11 p. 1132-
1 p.
artikel
22 A novel role for C5a as a regulator of B1 cell biology Figge, Julia
2012
217 11 p. 1133-
1 p.
artikel
23 Antibodies against chimeric pneumococcal proteins enhance complement deposition on Streptococcus pneumoniae with different genetic backgrounds Darrieux, Michelle
2012
217 11 p. 1139-
1 p.
artikel
24 Anticomplementary activity of horse IgG and F(ab′)2 antivenoms Squaiella-Baptistão, Carla Cristina
2012
217 11 p. 1140-
1 p.
artikel
25 A possible role of MAP-1 in skeletal muscle regeneration Munthe-Fog, Lea
2012
217 11 p. 1130-
1 p.
artikel
26 A rapid and reliable method to detect homozygous CFHR1 deletion and its association with anti-factor H antibodies in atypical hemolytic uremic syndrome Valoti, Elisabetta
2012
217 11 p. 1133-
1 p.
artikel
27 A role for C1q in normal brain aging Stephan, Alexander H.
2012
217 11 p. 1133-
1 p.
artikel
28 Assay for the pattern-recognition molecule CL-L1 Axelgaard, Esben
2012
217 11 p. 1140-
1 p.
artikel
29 A study of 46 atypical HUS mutations reveals that C3 and factor H mutations mirror each other on protein surfaces, engaged in the C3b–FH complex Roumenina, Lubka T.
2012
217 11 p. 1134-
1 p.
artikel
30 A user-friendly method to study the effect of FH and impact of FB variants on C3bBb convertase and C3bB proconvertase formation Bettoni, Serena
2012
217 11 p. 1134-
1 p.
artikel
31 Author Index 2012
217 11 p. I-XII
nvt p.
artikel
32 Autoregulation of thromboinflammation on biomaterials and cells by a novel therapeutic coating technique Teramura, Yuji
2012
217 11 p. 1140-
1 p.
artikel
33 Beta 2-glycoprotein I derived-peptides attenuate complement-mediated intestinal damage Fleming, Sherry D.
2012
217 11 p. 1141-
1 p.
artikel
34 Binding of iC3b to human dendritic cells does not alter the cells’ phenotype and functions Bajtay, Zsuzsa
2012
217 11 p. 1141-
1 p.
artikel
35 Bride and groom in systemic inflammation – The bells ring for complement and Toll in cooperation Barratt-Due, Andreas
2012
217 11 p. 1047-1056
10 p.
artikel
36 Bringing compstatin to the next level: Novel analogs with improved potency, pharmacokinetic profiles and administration options suitable for systemic application Ricklin, Daniel
2012
217 11 p. 1141-
1 p.
artikel
37 C3a and C5a mediated signalling on pulmonary CD103+ dendritic cells is critical for their migratory function in response to influenza infection Kandasamy, Matheswaran
2012
217 11 p. 1144-
1 p.
artikel
38 C5a/C5aR interaction mediates complement activation and thrombosis on endothelial cells in atypical hemolytic uremic syndrome (aHUS) Gastoldi, Sara
2012
217 11 p. 1145-1146
2 p.
artikel
39 C5a–C5aR interaction promotes kidney infection through acting on both renal and circulating cells Li, Ke
2012
217 11 p. 1145-
1 p.
artikel
40 C5a/C5aR signaling is an important negative regulator of murine nature killer cell homeostasis and effector function Li, Ke
2012
217 11 p. 1146-
1 p.
artikel
41 C5a is a target to prevent peritoneal tissue damage in acute peritoneal injury in rats Mizuno, Tomohiro
2012
217 11 p. 1144-
1 p.
artikel
42 C5aR contributes to adipose tissue inflammation and insulin resistance Phieler, Julia
2012
217 11 p. 1146-
1 p.
artikel
43 C5aR-dependent cell activation by physiological concentrations of C5a-desArg: Insights from a novel label-free cellular assay Reis, Edimara S.
2012
217 11 p. 1147-
1 p.
artikel
44 C5aR-dependent subversion of neutrophils and dysbiotic inflammation Hajishengallis, George
2012
217 11 p. 1147-1148
2 p.
artikel
45 C5a receptor signalling in dendritic cells regulates the development of maladaptive Th2 and Th17 immune responses in experimental allergic asthma Schmudde, Inken
2012
217 11 p. 1145-
1 p.
artikel
46 C5aR regulates intestinal microbiota composition and controls the induction of gastrointestinal allergic hypersensitivity Reinicke, Anna T.
2012
217 11 p. 1147-
1 p.
artikel
47 CD46 costimulation leads to enhanced T cell activation and microrna expression King, Benjamin C.
2012
217 11 p. 1148-1149
2 p.
artikel
48 CD59 deficiency is associated with chronic hemolysis and chronic inflammatory polyradiculoneuropathy Mevorach, Dror
2012
217 11 p. 1220-
1 p.
artikel
49 CD36 is not involved in alternative pathway-mediated complement-dependent cytotoxicity on proximal tubular epithelial cells Kenawy, Hany Ibrahim
2012
217 11 p. 1148-
1 p.
artikel
50 CD20 mAb-mediated C3b deposition and complement dependent cytotoxicity of tumor cells is enhanced by blocking the action of Factor I Taylor, Ronald P.
2012
217 11 p. 1148-
1 p.
artikel
51 CFHR1 gene variants and their pathophysiological relevance Tortajada, Agustin
2012
217 11 p. 1149-
1 p.
artikel
52 CFHR5 nephropathy in a family without Cypriot ancestry Medjeral-Thomas, Nicholas
2012
217 11 p. 1149-
1 p.
artikel
53 C3-glomerulopathy associated human factor H-related proteins 2 (CFHR2) and 5 (CFHR5) regulate complement C3b and TCC Eberhardt, Hannes U.
2012
217 11 p. 1143-
1 p.
artikel
54 Characterization of a human bispecific antibody against CD20/CD55 for the treatment of burkitt lymphoma Macor, Paolo
2012
217 11 p. 1149-1150
2 p.
artikel
55 Chemotherapy of breast cancer patients induces a shift in the glycosylation pattern of plasma complement components C3 and C4 Oehler, Rudolf
2012
217 11 p. 1150-
1 p.
artikel
56 C5 inhibition in mice prevents fatal C3 glomerulopathy Lesher, Allison
2012
217 11 p. 1144-
1 p.
artikel
57 C1-inhibitor efficiently inhibits Escherichia coli-induced tissue factor mRNA up-regulation, monocyte tissue factor expression and coagulation activation in human whole blood Landsem, Anne
2012
217 11 p. 1142-
1 p.
artikel
58 C1-INH rescues erythrocytes from complement mediated destruction in autoimmune hemolytic anemia Wouters, Diana
2012
217 11 p. 1142-
1 p.
artikel
59 C1 interaction with Trypanosoma cruzi calreticulin mediates ex vivo infection of human placenta Castillo, Christian
2012
217 11 p. 1141-1142
2 p.
artikel
60 Cleavage of intracellular C3 into C3a and C3b by cathepsin L is required for human TH1 induction Liszewski, Kathy M.
2012
217 11 p. 1150-
1 p.
artikel
61 Clinical analysis of peri-operative complement activation during renal ischemia-reperfusion injury following transplantation Blogowski, Wojciech
2012
217 11 p. 1150-1151
2 p.
artikel
62 CMAP: Putting complement on the map – one interaction at a time Reis, Edimara S.
2012
217 11 p. 1151-
1 p.
artikel
63 Collagen-binding MSCRAMMS of Gram-positive bacteria inhibit complement activation via the classical pathway Ya-Ping, Ko
2012
217 11 p. 1151-
1 p.
artikel
64 Collectin-11 (CL-K1):MASPs complex formation triggers activation of the complement lectin pathway—The fifth lectin pathway initiation complex Ma, Ying Jie
2012
217 11 p. 1152-
1 p.
artikel
65 Combined inhibition of complement and CD14 efficiently attenuated the inflammatory response induced by Staphylococcus aureus in a human whole blood model Skjeflo, Espen
2012
217 11 p. 1152-1153
2 p.
artikel
66 Combined inhibition of complement (C5) and CD14 markedly attenuates blood thrombogenicity, inflammation and hemodynamic changes in porcine sepsis Barratt-Due, Andreas
2012
217 11 p. 1152-
1 p.
artikel
67 Complement activation and cell activation in the Alzheimer brain Stretton, Alexandra
2012
217 11 p. 1153-
1 p.
artikel
68 Complement activation and phagocytosis in vitro of two strains of Borrelia burgdorferi S.L Sandholm, Kerstin
2012
217 11 p. 1153-
1 p.
artikel
69 Complement activation mediates placental ischemia-induced hypertension in the rat independent of vascular endothelial growth factor Regal, Jean F.
2012
217 11 p. 1153-1154
2 p.
artikel
70 Complement activity and regulation in premature, late premature and term neonates Grumach, A.S.
2012
217 11 p. 1154-
1 p.
artikel
71 Complement alternative pathway activation is associated with severity of nonalcoholic steatohepatitis Segers, Filip M.E.
2012
217 11 p. 1154-
1 p.
artikel
72 Complement alternative pathway score and broad spectrum of acquired and hereditary complement abnormalities in patients with C3 glomerulopathy Le Quintrec, Moglie
2012
217 11 p. 1155-
1 p.
artikel
73 Complement anaphylatoxin C5a supports ovarian cancer development and controls the expression of VEGF164/165 isoforms Nunez-Cruz, Selene
2012
217 11 p. 1155-
1 p.
artikel
74 Complement and antibody mediated killing of OPA-negative Neisseria gonorrhoeae by human neutrophils Agarwal, Sarika
2012
217 11 p. 1155-1156
2 p.
artikel
75 Complement and dysbiosis in periodontal disease Hajishengallis, George
2012
217 11 p. 1111-1116
6 p.
artikel
76 Complement- and platelet-mediated shuttling of blood-borne bacteria to CD8A+ dendritic cells Broadley, Steven
2012
217 11 p. 1160-
1 p.
artikel
77 Complement C5a and immune-complexes promote TNFα-dependent pathologies via stimulation of tace Issuree, Priya D.A.
2012
217 11 p. 1156-
1 p.
artikel
78 Complement C3 predicts cardiovascular event during 12 months of follow-up in haemodialysis patients and declines significantly with time on haemodialysis Carter, Angela W.
2012
217 11 p. 1156-
1 p.
artikel
79 Complement C1q production by osteoclasts and its regulation of osteoclast development Teo, Boon Heng
2012
217 11 p. 1220-
1 p.
artikel
80 Complement dependency of cholesterol crystal-induced inflammation – II. Inflammasome activation and regulation mechanisms involving reconstituted high density lipoprotein (HDL) and C-reactive protein (CRP) Niyonzima, Nathalie
2012
217 11 p. 1157-
1 p.
artikel
81 Complement dependency of cholesterol crystal-induced inflammation – I. Pathway activation mechanisms, cytokine responses and endothelial cell activation Nymo, Stig
2012
217 11 p. 1157-
1 p.
artikel
82 Complement dysregulation and disease: From genes and proteins to diagnostics and drugs de Cordoba, Santiago Rodriguez
2012
217 11 p. 1034-1046
13 p.
artikel
83 Complement in action: An analysis of patent trends from 1976 through 2011 DeAngelis, Robert A.
2012
217 11 p. 1157-1158
2 p.
artikel
84 Complement inhibition is neuroprotective in a mouse model of leprosy Idrissi, Nawal Bahia el
2012
217 11 p. 1158-
1 p.
artikel
85 Complement inhibitor C4b-binding protein is involved in protein AA amyloidosis Sjölander, Jonatan
2012
217 11 p. 1158-
1 p.
artikel
86 Complement levels and complement activation in neuromyelitis optica Füst, George
2012
217 11 p. 1216-
1 p.
artikel
87 Complement mediated adverse drug effects: Prediction with complement assays and prevention with tolerance induction Szebeni, Janos
2012
217 11 p. 1158-1159
2 p.
artikel
88 Complement mediated protection against Streptococcus pneumoniae induced by PspA–PdT immunization Goulart, Cibelly
2012
217 11 p. 1159-
1 p.
artikel
89 Complement pathways in periodontitis and targeted therapeutic intervention Abe, Toshiharu
2012
217 11 p. 1159-
1 p.
artikel
90 Complement receptor C3aR modulates platelet function and thrombosis Sauter, Reinhard J.
2012
217 11 p. 1160-
1 p.
artikel
91 Complement system modulation as a target for treatment of arrhythmogenic right ventricular dysplasia/cardiomyopathy Davos, Konstantinos
2012
217 11 p. 1218-
1 p.
artikel
92 Compstatin induces allosteric changes in C3 and C3b and changes their ligand binding pattern Chen, Hui
2012
217 11 p. 1160-
1 p.
artikel
93 Consumption and dysregulation of complement classical and alternative pathways in patients with streptococcus pneumoniae-associated haemolytic uremic syndrome Szilagyi, Agnes
2012
217 11 p. 1219-
1 p.
artikel
94 Control of arthritis by local synthesis of recombinant antibody neutralizing C5 Macor, Paolo
2012
217 11 p. 1160-1161
2 p.
artikel
95 C1q induces a program of gene expression in amyloid beta injured neurons necessary for neuron survival Benoit, Marie E.
2012
217 11 p. 1143-
1 p.
artikel
96 C1q negatively regulates monocyte activation by IFN-alpha derived from plasmacytoid dendritic cells Li, Nan
2012
217 11 p. 1220-
1 p.
artikel
97 C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation Bulla, Roberta
2012
217 11 p. 1143-
1 p.
artikel
98 CR3-bearing monocytes are protective in experimental tubulointerstitial nephritis (TIN) Chaves, Lee D.
2012
217 11 p. 1161-
1 p.
artikel
99 CR3 is the main phagocytotic receptor for iC3b opsonized particles on dendritic cells while CR4 plays supporting role Sándor, Noémi
2012
217 11 p. 1161-
1 p.
artikel
100 Critical role of C5aR signals in bone marrow-derived cells in an accelerated lupus nephritis model Bao, Lihua
2012
217 11 p. 1161-1162
2 p.
artikel
101 Crry deficiency exacerbates atherosclerosis in apoE deficient mice Jayanthi, Archana
2012
217 11 p. 1162-
1 p.
artikel
102 CSMD1 protein, a new complement inhibitor Escudero-Esparza, Astrid
2012
217 11 p. 1162-
1 p.
artikel
103 Deciphering the interactions of Streptococcus pyogenes and the complement system using a novel mouse infection model Ermert, David
2012
217 11 p. 1163-
1 p.
artikel
104 Deletion of Crry and DAF on murine platelets stimulates thrombopoiesis and increases fH-dependent resistance of peripheral platelets to complement attack Barata, Lidia
2012
217 11 p. 1163-
1 p.
artikel
105 De novo protein design of agonists and antagonists of C5a receptors Monk, Peter N.
2012
217 11 p. 1162-1163
2 p.
artikel
106 Determinants of the substrate specificity of the complement initiating protease, C1r Wijeyewickrema, Lakshmi C.
2012
217 11 p. 1163-1164
2 p.
artikel
107 Developmental abnormalities in Masp1/3-deficient mice Takahashi, Minoru
2012
217 11 p. 1164-
1 p.
artikel
108 Development of an anti-C5/C5a antibody therapeutic that inhibits inflammatory responses via C5aR and C5L2 while maintaining MAC-dependent bactericidal functions An, Ling-Ling
2012
217 11 p. 1219-
1 p.
artikel
109 Development of humanized complement factor H transgenic mice to interrogate the effect of age-related macular degeneration risk associated variants in vivo Kelly, Una
2012
217 11 p. 1164-
1 p.
artikel
110 Distinct roles of the complement C5a receptors C5aR and C5L2 in bacterial and bacterial component-induced inflammation in human whole blood An, Ling-Ling
2012
217 11 p. 1164-1165
2 p.
artikel
111 Does Salmonella lipopolysaccharides with sialic acid inhibit C3 activation? Futoma-Koloch, Bozena
2012
217 11 p. 1165-
1 p.
artikel
112 Editorial Board 2012
217 11 p. CO2-
1 p.
artikel
113 Effect of regulation of glycolysis on tumor inflammation and immune status Inoue, Norimitsu
2012
217 11 p. 1165-
1 p.
artikel
114 Effects of C1 esterase inhibitor on attenuation of ischemia/reperfusion injury in a rat hind limb model Dührkop-Sisewitsch, Claudia
2012
217 11 p. 1165-1166
2 p.
artikel
115 Effects of MASP-1 on blood coagulation studied by thrombelastometry Aeschliman, Judith
2012
217 11 p. 1166-
1 p.
artikel
116 Electron microscopy reveals coexistence of distinct conformations of iC3b Alcorlo, Martin
2012
217 11 p. 1166-
1 p.
artikel
117 Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis Skjoedt, Mikkel-Ole
2012
217 11 p. 1166-1167
2 p.
artikel
118 Endothelial cells injured by the thrombotic microangiopathy-inducing drug cyclosporin release complement-activating microparticles Renner, Brandon
2012
217 11 p. 1167-
1 p.
artikel
119 Enzymatic properties of the MASP-3 serine protease domain and crystal structure of its complex with ecotin Gaboriaud, Christine
2012
217 11 p. 1167-
1 p.
artikel
120 Escherichia coli-induced coagulation activation and pentraxin 3 release is highly dependent on complement and CD14 Brekke, Ole L.
2012
217 11 p. 1167-1168
2 p.
artikel
121 Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis Banda, Nirmal K.
2012
217 11 p. 1168-
1 p.
artikel
122 Evidence of classical complement activation during blood–biomaterial interaction in LDL apheresis Ludviksen, Judith Krey A.
2012
217 11 p. 1168-
1 p.
artikel
123 Evolution of the thioester-containing protein genes in the arthropoda Sekiguchi, Reo
2012
217 11 p. 1168-1169
2 p.
artikel
124 Expression of complement factors and functional C5a receptors in human embryonic stem cells, and induced pluripotent stem cells Hawksworth, Owen A.
2012
217 11 p. 1169-
1 p.
artikel
125 Expression of the complement system is upregulated in subcutaneous adipocytes from non-obese hypertriglyceridemic subjects and is associated with local insulin resistance Van Greevenbroek, Marleen M.J.
2012
217 11 p. 1169-
1 p.
artikel
126 Extracellular adherence protein (Eap) of Staphylococcus aureus evades innate immunity by inhibiting complement activation and neutrophil elastase Stapels, Daphne A.C.
2012
217 11 p. 1170-
1 p.
artikel
127 Factor H-dependent regulation of the alternative pathway of complement by Meningococci that lack FHBP, NSPA, capsule and lipooligosaccharide sialic acid Lewis, Lisa A.
2012
217 11 p. 1170-
1 p.
artikel
128 Factor XII missense mutation THR328LYS in three Brazilian families Cordeiro, Elisabete
2012
217 11 p. 1170-1171
2 p.
artikel
129 Familial membranoproliferative glomerulonephritis type I associated with a functionally significant mutation in complement factor H Wong, Edwin
2012
217 11 p. 1171-
1 p.
artikel
130 Ficolin-2 properties differ between serum and plasma Hein, Estrid
2012
217 11 p. 1171-
1 p.
artikel
131 Formation of an immune complex resembling C5b-9 via coagulation factors and platelets Gorham Jr., Ronald D.
2012
217 11 p. 1171-1172
2 p.
artikel
132 Free heme transforms endothelial cells into alternative pathway activators. Implications for the hemolytic and uremic syndrome Frimat, Marie
2012
217 11 p. 1172-
1 p.
artikel
133 Functional analyses of complement convertases using C3 and C5-depleted sera Okroj, Marcin
2012
217 11 p. 1221-1222
2 p.
artikel
134 Functional analysis of the complement system in oligoarticular juvenile idiopathic arthritis Brunner, Juergen K.H.
2012
217 11 p. 1172-
1 p.
artikel
135 Functional C1-inhibitor level increases during attacks of hereditary angioedema Varga, Lilian A.
2012
217 11 p. 1172-1173
2 p.
artikel
136 Galactosylated IgG1 immune complexes diminish C5a-dependent inflammation in experimental Epidermolysis Bullosa Acquisita Kilchenstein, Regina
2012
217 11 p. 1129-1130
2 p.
artikel
137 GAPDH exposed on human and pneumococcal cell surface is a novel C1q ligand Tacnet-Delorme, Pascale
2012
217 11 p. 1173-
1 p.
artikel
138 Global gene expression analysis of the effects of sublytic complement on CT26 colon carcinoma cells using microarray technology Towner, Laurence D.
2012
217 11 p. 1173-
1 p.
artikel
139 Higher levels of complement C3a (activated C3) are cross-sectionally associated with higher carotid media thickness and lower ankle-arm blood pressure index: The CODAM study Hertle, Elisabeth
2012
217 11 p. 1174-
1 p.
artikel
140 High performance fluid-based array using protein AG for coupling antibodies to carboxylated microspheres for quantification of 10 complement protein components Nascimento, Eduardo J.M.
2012
217 11 p. 1173-1174
2 p.
artikel
141 How does degradation of neutrophil extracellular traps correlate with the activity of systemic lupus erythematosus? Leffler, Jonatan
2012
217 11 p. 1174-
1 p.
artikel
142 Human CR1 as a target for selective treatment of autoimmune and allergic diseases in humanised SCID mice Tchorbanov, Andrey I.
2012
217 11 p. 1174-1175
2 p.
artikel
143 Hunting for biomarkers: The complement system in Alzheimer's disease Hakobyan, Svetlana
2012
217 11 p. 1175-
1 p.
artikel
144 Identification of a novel C5a-inhibiting human and mouse-specific Spiegelmer® for treatment of septic shock and its proof of concept in the CLP mouse model Vater, Axel
2012
217 11 p. 1175-
1 p.
artikel
145 Identification of a novel mode of complement activation on stimulated platelets mediated by properdin Saggu, Gurpanna
2012
217 11 p. 1175-1176
2 p.
artikel
146 Identification of critical core amino acids of a major linear C1q epitope recognized by SLE auto-antibodies Vanhecke, Dominique
2012
217 11 p. 1176-
1 p.
artikel
147 Identification of Jagged1 as a novel ligand for CD46: An interaction required for normal induction and regulation of human TH1 responses Le Friec, Gaelle
2012
217 11 p. 1176-
1 p.
artikel
148 Identification of the gC1qR binding sites for HIV-1 gp41 and HCV core protein Pednekar, Lina
2012
217 11 p. 1177-
1 p.
artikel
149 IgG2a immune complexes enhance C5a-mediated inflammation Wagner, Marina
2012
217 11 p. 1177-
1 p.
artikel
150 IgM-mediated enhancement of immune responses Ding, Zhoujie
2012
217 11 p. 1177-1178
2 p.
artikel
151 Immune evasion in leptospira: The secretion of metalloproteases that directly cleave complement proteins Fraga, Tatiana R.
2012
217 11 p. 1178-
1 p.
artikel
152 Inhibition of ABO incompatibility using a novel small peptide Sharp, Julia A.
2012
217 11 p. 1178-1179
2 p.
artikel
153 Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantation Kourtzelis, Ioannis
2012
217 11 p. 1179-
1 p.
artikel
154 Inhibition of complement-dependent cytotoxicity by C9-binding cellular stress proteins Rozenberg, Perri
2012
217 11 p. 1179-
1 p.
artikel
155 Interactions of the complement system with molecules of extracellular matrix: Relevance for joint diseases Happonen, Kaisa E.
2012
217 11 p. 1088-1096
9 p.
artikel
156 Interactions of the humoral pattern recognition molecule PTX3 with the complement system Doni, Andrea
2012
217 11 p. 1122-1128
7 p.
artikel
157 Investigation of complement activation by neutral liposomes Klapper, Yvonne
2012
217 11 p. 1179-1180
2 p.
artikel
158 In vivo dissection of the contribution of fB, fD and properdin to alternative pathway activation on membranes Wu, Xiaobo
2012
217 11 p. 1178-
1 p.
artikel
159 Involvement of the murine epididymal C4BP in the reproductive system but not in the complement system Nonaka, Mayumi I.
2012
217 11 p. 1180-
1 p.
artikel
160 Knockdown of the membrane regulators CD46, CD55, CD59 by sirna enhances complement- and macrophage-dependent anti-tumor effects of rituximab and Campath-1H Mamidi, Srinivas
2012
217 11 p. 1180-
1 p.
artikel
161 Large-scale generation of IgG-depleted human complement source for functional bacterial immunoassays Brookes, Charlotte
2012
217 11 p. 1181-
1 p.
artikel
162 Large spectrum of Factor B aHUS mutations functional consequences on the C3 convertase – From gain to lack of functional consequence Roumenina, Lubka T.
2012
217 11 p. 1180-1181
2 p.
artikel
163 Leptospiral immunoglobulin-like proteins interact with plasminogen to escape complement mediated-killing Valencia, Mónica M.C.
2012
217 11 p. 1181-
1 p.
artikel
164 Ligand-induced dimerisation of the complement C5aR and C5L2 receptors by C5a but not C5a-des Arg Croker, Daniel E.
2012
217 11 p. 1181-1182
2 p.
artikel
165 LJM19, a salivary protein from the sand fly vector that transmits leishmaniasis, is a novel inhibitor of the classical pathway of complement Ferreira, Viviana P.
2012
217 11 p. 1182-
1 p.
artikel
166 Local and not systemic factor H production dictates risk of age-related macular degeneration in liver transplant recipients Khandhadia, Sam
2012
217 11 p. 1182-1183
2 p.
artikel
167 Localised inhibition of coagulation limits acute complement mediated damage in high risk renal transplantation Karegli, Julieta
2012
217 11 p. 1183-
1 p.
artikel
168 Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients – A case–control study nested within the Swiss HIV Cohort Study Egli, Adrian
2012
217 11 p. 1183-
1 p.
artikel
169 Maggot excretions and secretions reduce complement activation Cazander, Gwendolyn
2012
217 11 p. 1184-
1 p.
artikel
170 Manipulating the mediator: Modulation of the alternative complement pathway C3 convertase in health, disease and therapy Ricklin, Daniel
2012
217 11 p. 1057-1066
10 p.
artikel
171 Mannan-binding lectin associated serine protease-3 is a novel predictor of overall survival in patients with metastatic renal cell carcinoma Jensenius, Jens C.
2012
217 11 p. 1184-
1 p.
artikel
172 Mannan-binding lectin in pregnancy: Analysis of serum concentrations/genotypes with regard to clinical data in 212 women Potlukova, Eliska
2012
217 11 p. 1184-1185
2 p.
artikel
173 Mannose-binding lectin and lectin pathway in subarachnoid hemorrhage patients Zangari, Rosalia
2012
217 11 p. 1185-
1 p.
artikel
174 Mannose-binding lectin deficiency reduces functional deficits and histological damage after experimental traumatic brain injury Longhi, Luca
2012
217 11 p. 1185-
1 p.
artikel
175 MASP-1 is crucial for lectin pathway activation in human serum, while neither MASP-1 nor MASP-3 are required for alternative pathway function Degn, Soren E.
2012
217 11 p. 1218-1219
2 p.
artikel
176 MASP levels in cardio- and cerebrovascular diseases: A pilot study Frauenknecht, Vera
2012
217 11 p. 1186-
1 p.
artikel
177 MBL-associated serine protease (MASP)-1/3 promotes the initiation of the alternative pathway activation Kodama, Toshihisa
2012
217 11 p. 1186-
1 p.
artikel
178 MBL/ficolin associated protein-1 inhibits the complex formation between MASPs and MBL Rosbjerg, Anne
2012
217 11 p. 1186-
1 p.
artikel
179 MCP (CD46) autoantibodies are associated with atypical hemolytic uremic syndrome Bennaceur, Karim
2012
217 11 p. 1187-
1 p.
artikel
180 Membrane attack complex deposition on gram-positive bacteria Berends, Evelien T.M.
2012
217 11 p. 1187-
1 p.
artikel
181 Membrane cofactor protein (MCP) haplotype, which predisposes to atypical hemolytic and uremic syndrome, has no consequence on neutrophils and endothelial cells MCP levels or on HUVECs ability to activate complement frimat, Marie
2012
217 11 p. 1187-1188
2 p.
artikel
182 M-ficolin binds specifically to two capsulare structures of Streptococcus pneumoniae Kjaer, Troels
2012
217 11 p. 1183-1184
2 p.
artikel
183 Microbial pathogens of diverse origin inhibit the terminal complement pathway: A common immune evasion strategy? Hallström, Teresia
2012
217 11 p. 1188-
1 p.
artikel
184 Modulation of human T cell function by exogenous and endogenous C3 Erdei, Anna
2012
217 11 p. 1188-
1 p.
artikel
185 Molecular and functional characterization of the interaction of L-ficolin with Streptococcus pneumoniae Stermann, Emilie
2012
217 11 p. 1188-1189
2 p.
artikel
186 Natural inhibitors of the lectin pathway Paréj, Katalin
2012
217 11 p. 1189-
1 p.
artikel
187 Negative regulation of human nature killer cells by complement Min, Xiaoyun
2012
217 11 p. 1189-
1 p.
artikel
188 Negative regulation of NK cell function through engagement of CR3 with its complement ligand Li, Ke
2012
217 11 p. 1189-1190
2 p.
artikel
189 New crossroads between complement and apoptosis after trauma Huber-Lang, Markus S.
2012
217 11 p. 1190-
1 p.
artikel
190 New insights into the inhibitory function of CR1 on human B lymphocytes; the functional consequences of the crosstalk between BCR, TLR9 and CR1 Kremlitzka, Mariann
2012
217 11 p. 1190-
1 p.
artikel
191 NGR conjugated pegylated polymeric nanoparticles for targeted delivery of docetaxel Gupta, Madhu
2012
217 11 p. 1190-1191
2 p.
artikel
192 Non-proteolytically activated C3 promotes binding of activated platelets and platelet-derived microparticles to leukocytes via CD11b/CD18 Hamad, Osama A.
2012
217 11 p. 1191-
1 p.
artikel
193 Novel monoclonal antibodies to C3d that target and identify in living animals sites of complement activation Thurman, Joshua M.
2012
217 11 p. 1191-
1 p.
artikel
194 Novel mouse anti-mouse monoclonal antibodies that block either the ligand or receptor member of the CR2–C3d interaction pair impair antigen-specific humoral immune responses to model antigens Kulik, Liudmila
2012
217 11 p. 1192-
1 p.
artikel
195 Omeros_Advertisement 2012
217 11 p. XIII-
1 p.
artikel
196 On the conformational flexibility of C3b: A molecular insight into activation and transformation of a major complement effector Gipson, Bryant
2012
217 11 p. 1192-
1 p.
artikel
197 Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders Risitano, Antonio M.
2012
217 11 p. 1080-1087
8 p.
artikel
198 Peptide and protein inhibitors targeting the C3 convertase efficiently prevent surface C3 deposition and subsequent hemolysis of paroxysmal nocturnal hemoglobinuria (PNH) erythrocytes Risitano, Antonio M.
2012
217 11 p. 1217-
1 p.
artikel
199 Peripheral gangrenes in children with atypical hemolytic uremic syndrome Malina, Michal
2012
217 11 p. 1192-1193
2 p.
artikel
200 Phagocytosis of Escherichia coli in human whole blood: Early complement dependency is succeeded by late CD14 dependency over time Christansen, Dorte
2012
217 11 p. 1193-
1 p.
artikel
201 Pinpointing the time and cause of fetal demise in the Crry−/− embryo Triebwasser, Michael P.
2012
217 11 p. 1193-
1 p.
artikel
202 Poly-cation containing alginate microcapsules induce cytokines by a complement-dependent mechanism Rokstad, Anne Mari
2012
217 11 p. 1221-
1 p.
artikel
203 Preface Lambris, John D.
2012
217 11 p. 1025-
1 p.
artikel
204 Premolis semirufa envenomation, disease affecting rubber tappers of the Amazon: Searching for caterpillar-bristles toxic components acting on the complement system Boas, Isadora Maria Villas
2012
217 11 p. 1194-
1 p.
artikel
205 Pre-transplant ficolin-3 levels are associated with kidney allograft survival Bay, Jakob T.
2012
217 11 p. 1193-1194
2 p.
artikel
206 Production of functional full-length recombinant human C1q Bally, Isabelle
2012
217 11 p. 1194-
1 p.
artikel
207 Prolonged voltage-gated calcium channel activation by sublytic complement activation in retinal pigment epithelium, a mechanism for controlling VEGF secretion Rohrer, Bärbel
2012
217 11 p. 1194-1195
2 p.
artikel
208 Properdin and complement amplification loop in the pathogenesis of experimental autoimmune myasthenia gravis (EAMG) Soltys, Jindrich
2012
217 11 p. 1195-
1 p.
artikel
209 Properdin binding to the surface of leptospira promotes complement activation and controls proliferation of non-pathogenic bacteria in vitro Martínez, Adriana G.P.
2012
217 11 p. 1195-
1 p.
artikel
210 Properdin deficiency exacerbates C3 glomerulopathy in factor H-deficient mice Ruseva, Marieta M.
2012
217 11 p. 1196-
1 p.
artikel
211 Properdin is increased after allergen challenge of asthmatic patients and contributes to OVA-induced airway inflammation and AHR at the effector phase by enhancing C3a generation in mice Wang, Yuan
2012
217 11 p. 1196-
1 p.
artikel
212 Purification and biochemical characterization of functional complement factor H from human plasma fractions Brandstätter, Hubert
2012
217 11 p. 1196-
1 p.
artikel
213 Putting the structure into complement Lea, Susan M.
2012
217 11 p. 1117-1121
5 p.
artikel
214 Rat adipose tissue-derived stromal cells in a low serum medium attenuate peritoneal injuries in rat zymosan-induced peritonitis Kim, Hangsoo
2012
217 11 p. 1197-
1 p.
artikel
215 Rational engineering of a novel complement regulator-based therapeutic affords triple targeting of host surfaces and pathway-specific inhibition of complement activation Schmidt, Christoph Q.
2012
217 11 p. 1197-
1 p.
artikel
216 Recombinant anti-human and anti-porcine CD14 antibodies Lau, Corinna
2012
217 11 p. 1197-1198
2 p.
artikel
217 Recombinant mouse factor H from Pichia pastoris Kerr, Heather
2012
217 11 p. 1198-
1 p.
artikel
218 Reduced activity of the lectin complement pathway in cystic fibrosis Keizer, Sandrino M.P.D.
2012
217 11 p. 1198-
1 p.
artikel
219 Reduction of complement regulator CD59 expression on human kidney cells by Shiga toxin 2 Ehrlenbach, Silvia
2012
217 11 p. 1198-1199
2 p.
artikel
220 Regulation of complement in whole blood by heparin molecularly imprinted polymer particles Huang, Shan
2012
217 11 p. 1199-
1 p.
artikel
221 Response gene to complement-32 is a potential biomarker of relapses in multiple sclerosis Rus, Horea
2012
217 11 p. 1199-
1 p.
artikel
222 Robust measurement of rat complement system activation with novel ELISA-based assays Kotimaa, Juha P.
2012
217 11 p. 1199-1200
2 p.
artikel
223 Role of complement in a murine model of peanut-induced anaphylaxis Kodama, Toshihisa
2012
217 11 p. 1200-
1 p.
artikel
224 Role of complement in modulation of TH2 response in prostate cancer cells Yamamoto, Hidekazu
2012
217 11 p. 1200-
1 p.
artikel
225 Role of complement in the early stages of viral infections Langlois, Marie-Pierre
2012
217 11 p. 1200-1201
2 p.
artikel
226 Role of properdin in systemic AP complement consumption caused by Crry deficiency Lesher, Allison
2012
217 11 p. 1201-
1 p.
artikel
227 Role of the alternative pathway of complement in ischemia/reperfusion and chronic graft injury in a mouse model of kidney allograft Cavinato, Regiane Aparecida
2012
217 11 p. 1201-
1 p.
artikel
228 Saliva activates the complement system Gunput, Sabrina T.G.
2012
217 11 p. 1201-1202
2 p.
artikel
229 Screening patients with inherited GPI anchor deficiency to establish concept of the new disease Murakami, Yoshiko
2012
217 11 p. 1202-
1 p.
artikel
230 Serological analysis of complement in patients with neuromyelitis optica Nytrova, Petra
2012
217 11 p. 1202-
1 p.
artikel
231 Signals through CR3 generate alternatively activated macrophages (AAMs) which are protective in complement-dependent glomerulonephritis (GN) Alexander, Jessy J.
2012
217 11 p. 1203-
1 p.
artikel
232 Silencing of mortalin, a regulator of the complement membrane attack complex, as anticancer adjuvant therapy Donin, Natalie
2012
217 11 p. 1203-
1 p.
artikel
233 Species selectivity in poxviral complement regulators is dictated primarily by the charge reversal in the central complement control protein modules Yadav, Nand Viveka
2012
217 11 p. 1217-
1 p.
artikel
234 Specificity and mechanism of assembly of C4b binding protein Caesar, Joseph J.E.
2012
217 11 p. 1204-
1 p.
artikel
235 Specific serum immunoglobulin recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus Lee, Bok L.
2012
217 11 p. 1203-
1 p.
artikel
236 Staphylococcal proteases aid evasion of human complement system Jusko, Monika
2012
217 11 p. 1204-
1 p.
artikel
237 Staphylococcus aureus surface protein SdrE binds the complement regulator factor H to evade the immune response Sharp, Julia A.
2012
217 11 p. 1204-
1 p.
artikel
238 Structural basis for activation of the complement system by C4 cleavage Andersen, Gregers R.
2012
217 11 p. 1205-
1 p.
artikel
239 Structural characterization of the N-terminal region of Streptococcus pneumonia surface protein C Herbert, Andrew P.
2012
217 11 p. 1205-
1 p.
artikel
240 Structural comparison of the C-terminal domains of factor H and CFHR-1 suggests explanation for the location of a major autoantibody epitope in autoimmune aHUS Bhattacharjee, Arnab
2012
217 11 p. 1221-
1 p.
artikel
241 Structural findings in complement factor H-related proteins unravel the pathogenesis of C3 glomerulopathy de Jorge, Elena Goicoechea
2012
217 11 p. 1205-
1 p.
artikel
242 Survival of bacterial blood isolates in serum or blood can be impaired with factor H fragment CFH5–7 Haapasalo-Tuomainen, Karita
2012
217 11 p. 1205-1206
2 p.
artikel
243 Synchronized transcription of the three C1q genes in dendritic cells – Molecular and chromosomal mechanisms Tan, Carol Shurong
2012
217 11 p. 1206-
1 p.
artikel
244 Systemic CD14-inhibition attenuates local inflammatory responses organ-dependently in porcine Escherichia coli-sepsis Thorgersen, Ebbe Billmann
2012
217 11 p. 1206-
1 p.
artikel
245 Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis DeAngelis, Robert A.
2012
217 11 p. 1097-1105
9 p.
artikel
246 Targeted deep sequencing of the complement system in complementopathies Triebwasser, Michael P.
2012
217 11 p. 1206-1207
2 p.
artikel
247 Targeted silencing of mCRP (CD46, CD55, CD59) by siRNA encapsulated in transferrin-liposomes specifically sensitizes cancer cells to complement attack Mamidi, Srinivas
2012
217 11 p. 1207-
1 p.
artikel
248 Targeting MBL in cerebral ischemia induces long lasting protection with a wide therapeutic window Orsini, Franca
2012
217 11 p. 1207-
1 p.
artikel
249 Targeting the glomerular basement membrane to control unwanted complement activation Hunze, Eva-Maria
2012
217 11 p. 1208-
1 p.
artikel
250 Terminal complement pathway therapy in experimental traumatic brain injury Ramaglia, Valeria
2012
217 11 p. 1208-
1 p.
artikel
251 The C3a receptor mediates protection from intestinal ischemia reperfusion injuries by impairing neutrophil mobilization Woodruff, Trent M.
2012
217 11 p. 1209-
1 p.
artikel
252 The complement anaphylatoxin C3a is critical in generating both innate and adaptive immune responses to Listeria monocytogenes due to its indispensible role in immune cell survival Mueller-Ortiz, Stacey L.
2012
217 11 p. 1209-
1 p.
artikel
253 The complement anaphylatoxin C3a receptor (C3aR) contributes to the inflammatory response in acute dextran sulphate sodium (DSS)-induced colitis in mice Klos, Andreas
2012
217 11 p. 1209-1210
2 p.
artikel
254 The complement system in ischemia–reperfusion injuries Gorsuch, William B.
2012
217 11 p. 1026-1033
8 p.
artikel
255 The C-type lectin of the aggrecan G3 domain activates complement Fürst, Camilla Melin
2012
217 11 p. 1208-
1 p.
artikel
256 The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer models and acts by CR2-dependent targeting of CR1 regulatory activity Holers, Michael
2012
217 11 p. 1210-
1 p.
artikel
257 The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases Karsten, Christian M.
2012
217 11 p. 1067-1079
13 p.
artikel
258 The interference of genetic background of C57Bl/6 and A/J mice on the development of acute and chronic inflammatory response induced by ethanol: Possible contribution of C5 Bavia, Lorena
2012
217 11 p. 1210-
1 p.
artikel
259 The lectin pathway triggered by activated platelets Kozarcanin, Huda
2012
217 11 p. 1130-
1 p.
artikel
260 The novel Jagged1/CD46 interaction: A prime target for immune modulation by viruses? Sheppard, Devon
2012
217 11 p. 1210-1211
2 p.
artikel
261 Therapeutic application of recombinant properdin confers a significant degree of protection during Neisseria meningitidis infection Ali, Youssif M.
2012
217 11 p. 1214-
1 p.
artikel
262 The ratio between C4 and C4BP adsorbed from plasma predicts cytokine generation induced by artificial polymers in contact with whole blood Engberg, Anna E.
2012
217 11 p. 1211-
1 p.
artikel
263 The role of complement in bone healing: Fracture healing in C3 and C5-deficient mice Ehrnthaller, Christian M.
2012
217 11 p. 1211-
1 p.
artikel
264 The role of properdin in zymosan- and Escherichia coli-induced complement activation Harboe, Morten
2012
217 11 p. 1212-
1 p.
artikel
265 The role of the complement pathway in neuronal migration in the developing brain Gorelik, Anna
2012
217 11 p. 1212-
1 p.
artikel
266 The roles of the C5a receptor on the human erythroleukaemia K562 cells during the hemin-induced erythropoiesis Nishiura, Hiroshi
2012
217 11 p. 1217-
1 p.
artikel
267 The salivary scavenger and agglutinin (SALSA) binds MBL and regulates the lectin pathway of complement in solution and on surfaces Reichhardt, Martin P.
2012
217 11 p. 1212-
1 p.
artikel
268 The surface binding region of complement Factor H guides the staphylococcal Efb to cell surfaces to allow local complement inhibition Boehm, Sascha
2012
217 11 p. 1213-
1 p.
artikel
269 The systemic inflammatory reaction in polymicrobial sepsis induced by murine cecal ligation and puncture is equally dependent on C5 and CD14 Mollnes, Tom E.
2012
217 11 p. 1129-
1 p.
artikel
270 The tick-over theory revisited: Is C3 a contact-activated protein? Nilsson, Bo
2012
217 11 p. 1106-1110
5 p.
artikel
271 The use of ‘real-time’ complement analysis to differentiate atypical hemolytic uraemic syndrome from other forms of thrombotic microangiopathies Prohaszka, Zoltan
2012
217 11 p. 1213-
1 p.
artikel
272 The zymogen form of the catalytic region of the complement protease, C1s, is stabilized into a form unable to interact with substrates and cofactors Pike, Robert N.
2012
217 11 p. 1213-1214
2 p.
artikel
273 Thrombin induces complement production and modulates T cell responses by dendritic cells (DCs) in kidney transplant recipients with delayed graft function (DGF) Pontrelli, Paola
2012
217 11 p. 1214-
1 p.
artikel
274 Towards a new model for the C1q – Calreticulin interaction at the phagocytic synapse Touch, Sothea
2012
217 11 p. 1214-1215
2 p.
artikel
275 Trypanosoma cruzi calreticulin inhibits the classical pathway of complement activation in Gallus gallus Abello, Paula
2012
217 11 p. 1215-
1 p.
artikel
276 Type I CD20 antibodies take over the B-cell receptor for complement-dependent cytotoxicity (CDC) of malignant B cells Engelberts, Patrick J.
2012
217 11 p. 1218-
1 p.
artikel
277 VEGF-A regulates glomerular endothelial cell expression of protective complement regulators involved in the pathogenesis of atypical haemolytic uraemic syndrome Keir, Lindsay S.
2012
217 11 p. 1215-
1 p.
artikel
278 Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and VSV to neutralization Johnson, John B.
2012
217 11 p. 1215-1216
2 p.
artikel
279 Why eculizumab as treatment for EHEC-induced haemolytic uraemic syndrome? Orth, Dorothea
2012
217 11 p. 1216-
1 p.
artikel
                             279 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland